On October 29, 2025, Curve Biosciences, the Whole-Body Intelligence™ company, announced it has raised $40 million in funding led by Luma Group with participation from First Spark Ventures, Techas Capital, Micah Spear, Civilization Ventures, LifeX Ventures, Incite, Mintaka VC, NZVC, and others. The funding will advance the clinical validation and commercialization of Curve’s Whole-Body Intelligence platform to transform chronic disease monitoring.

Wilson Sonsini Goodrich & Rosati advised Curve on the transaction. The team included Elton Satusky, Roy Argand, Davelyn Bulovas, and Isaac Reed.

For more information, please see Curve’s news release.